Edward Bailey - CSL Company Secretary

CSLLY Stock  USD 86.92  1.04  1.18%   

Executive

Mr. Edward H. Bailey B.ComLLB, FCIS, serves as Australian General Counsel of the Company. He was Australian General Counsel, Company Secretary of CSL Limited. He joined CSL Limited in 2000 and had occupied the role of Assistant Company Secretary from 2001. Before joining CSL Limited, Mr. Bailey was Senior Associate with Arthur Robinson Hedderwicks. since 2017.
Age 50
Tenure 7 years
Phone61 3 9389 1911
Webhttps://www.csl.com.au

CSL Management Efficiency

The company has return on total asset (ROA) of 0.0613 % which means that it generated a profit of $0.0613 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1338 %, meaning that it generated $0.1338 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 3.86 B in total debt with debt to equity ratio (D/E) of 0.66, which is about average as compared to similar companies. CSL has a current ratio of 2.27, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CSL until it has trouble settling it off, either with new capital or with free cash flow. So, CSL's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CSL sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CSL to invest in growth at high rates of return. When we think about CSL's use of debt, we should always consider it together with cash and equity.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people. CSL [CSLLY] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

CSL Leadership Team

Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul McKenzie, Chief Officer
Alan Wills, Senior Vice President of Strategy and Business Development
BS BS, Exec Counsel
Val Romberg, Executive Vice President of Manufacturing and Planning
Edward Bailey, Company Secretary
Brian McNamee, Non-Executive Independent Director
Bill Campbell, Executive Vice President Chief Commercial Officer
Wilfried Freudenberg, Department Production
Bob Repella, Executive Vice President - Global Commercial Operations
Abbas Hussain, Director
Bernard Ronchi, Senior Manager, Investor Relations
Laurie Cowan, Sr. VP of HR
MS BA, Ex Officer
Greg Boss, Group General Counsel, Executive Vice President - Legal
John Akehurst, Independent Non-Executive Director
Karen Etchberger, Executive VP of Quality and Bus. Services
Jemimah Brennan, Head Pacific
Mark Dehring, Head of Investor Relations
Fiona Mead, Company Secretary and Head of Group Governance
Andrew Cuthbertson, Chief Scientific Officer, R&D Director
Megan Clark, Director
Paul Perreault, CEO, Managing Director, Executive Director
Robert Cuthbertson, Chief Scientific Officer, R&D Director, Director
David Anstice, Independent Non-Executive Director
Shah Hussain, Director
Paul BA, CEO MD
Bruce Brook, Independent Non-Executive Director
Christine OReilly, Independent Non-Executive Director
Mary Sontrop, Executive Vice President - Manufacturing and Planning
BCom BComm, Chief Officer
Gordon Naylor, CFO
David Lamont, CFO
Laurie Reed, Senior Vice President - Human Resources
Tadataka Yamada, Director
Elizabeth Walker, Chief Human Resource Officer, Executive Vice President
Christina Hickie, Sr Communications
Marie McDonald, Independent Non-Executive Director
John Shine, Independent Non-Executive Chairman of the Board
Maurice Renshaw, Independent Non-Executive Director
Robert Repella, Executive Vice President - Global Commercial Operations
John Levy, Company Secretary

CSL Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CSL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CSL

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CSL position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will appreciate offsetting losses from the drop in the long position's value.

Moving together with CSL Pink Sheet

  0.86CMXHF CSL LimitedPairCorr

Moving against CSL Pink Sheet

  0.52NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.51NONOF Novo Nordisk ASPairCorr
  0.48SGEN Seagen Inc Earnings Call This WeekPairCorr
  0.45AXP American Express Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to CSL could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CSL when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CSL - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CSL to buy it.
The correlation of CSL is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CSL moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CSL moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CSL can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSL. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for CSL Pink Sheet analysis

When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Please note, there is a significant difference between CSL's value and its price as these two are different measures arrived at by different means. Investors typically determine if CSL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CSL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.